RecruitingNot ApplicableNCT06089161

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks


Sponsor

University of Miami

Enrollment

330 participants

Start Date

Mar 19, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).


Eligibility

Min Age: 60 YearsMax Age: 85 Years

Inclusion Criteria5

  • Self-reported race/ethnicity as African American, African, Caribbean or black
  • Ages 60-85 years
  • accessible by phone
  • OSA diagnosis
  • consent, including permission to release medical data

Exclusion Criteria4

  • progressive illnesses in which disability or death is expected within 1 year
  • impaired cognitive/ functional ability precluding participation
  • intention to move within the year
  • and a family member currently enrolled.

Interventions

OTHERStandard of Care

Participants in this group will receive standard of care treatment for sleep apnea.

BEHAVIORALPersonalized OSA Treatment

Participants in this group will receive standard of care treatment plus the personalized treatment that consists of videos approximately three minutes long, virtual, accessed through web based application, that the participant watches weekly. The purpose of the video is tailored educational content for sleep apnea.


Locations(1)

University of Miami

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06089161


Related Trials